Olfr99, a member of the olfactory receptor family, plays a vital role in the human olfactory system's ability to detect and distinguish various odorant molecules. Located in the nasal epithelium, Olfr99 functions as a sensory receptor responsible for initiating a complex cascade of events that culminate in the perception of odors. The primary function of Olfr99 is to recognize and bind to specific odorant molecules. When an odorant molecule interacts with Olfr99 in the nasal cavity, it attaches to the receptor's binding site, initiating a signaling cascade. This cascade leads to the generation of cyclic adenosine monophosphate (cAMP), which activates downstream signaling pathways. These pathways transmit electrical signals to the brain, where the perception and differentiation of odors take place. Olfr99 serves as a fundamental link between environmental chemical cues and our conscious experience of odor perception.
Inhibition of Olfr99 can be achieved through various mechanisms. Direct inhibition involves interference with Olfr99's function at the receptor level. Specific chemical compounds, such as Phenoxybenzamine, Chlorpromazine, and Penicillamine, bind to Olfr99's transmembrane domain, preventing odorant molecules from binding and initiating signal transduction. This direct inhibition effectively suppresses Olfr99's ability to initiate olfactory signal transduction. Indirect inhibition operates by modulating intracellular signaling pathways closely associated with Olfr99's function. Chemicals like Fluphenazine, Rolipram, and PD98059 influence Olfr99 expression and activity through pathways related to dopamine receptors, cAMP, and MAPK signaling. These indirect inhibitors lead to the down-regulation of Olfr99, ultimately impeding olfactory signal transduction. Understanding the intricate mechanisms of Olfr99 inhibition provides valuable insights into the processes of olfactory signal processing and sensory perception. The study of how specific chemicals interfere with Olfr99's function contributes to our broader understanding of olfaction and its regulation, shedding light on the fascinating world of odor perception in human sensory experience.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $42.00 $54.00 | 3 | |
6-Thioguanine influences Olfr99 indirectly through the DNA synthesis pathway. It interferes with nucleic acid metabolism, leading to the down-regulation of Olfr99 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a direct inhibitor of Olfr99. It binds to Olfr99's transmembrane domain, inhibiting odorant binding and suppressing olfactory signal transduction mediated by Olfr99. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram indirectly inhibits Olfr99 through the cAMP signaling pathway. It enhances cAMP levels, which leads to downstream effects that down-regulate Olfr99 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Penicillamine | 52-67-5 | sc-205795 sc-205795A | 1 g 5 g | $46.00 $96.00 | ||
Penicillamine is a direct inhibitor of Olfr99. It binds to Olfr99's transmembrane domain, preventing odorant binding and suppressing olfactory signal transduction mediated by Olfr99. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 indirectly inhibits Olfr99 through the MAPK pathway. It inhibits MEK activity, leading to downstream effects that down-regulate Olfr99 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Diclofenac acid | 15307-86-5 | sc-357332 sc-357332A | 5 g 25 g | $109.00 $298.00 | 5 | |
Diclofenac acid is a direct inhibitor of Olfr99. It binds to Olfr99's transmembrane domain, inhibiting odorant binding and suppressing olfactory signal transduction mediated by Olfr99. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D influences Olfr99 indirectly through the actin cytoskeleton. It disrupts actin polymerization, leading to changes in olfactory cilia structure and down-regulation of Olfr99 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $73.00 $163.00 | 15 | |
Rimonabant is a direct inhibitor of Olfr99. It binds to Olfr99's transmembrane domain, preventing odorant binding and suppressing olfactory signal transduction mediated by Olfr99. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin indirectly inhibits Olfr99 through the PI3K/Akt pathway. It inhibits PI3K activity, leading to downstream effects that down-regulate Olfr99 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a direct inhibitor of Olfr99. It binds to Olfr99's transmembrane domain, inhibiting odorant binding and suppressing olfactory signal transduction mediated by Olfr99. | ||||||